Products Products
Mutual Funds
Stock Market
NPS Retirement Funds

Company Company
About us
Contact us
1000002102
Paytm
Mutual Funds Stock Market NPS Retirement Funds
About us Contact us

Astrazeneca Pharma

8700.50
-267.00 (-2.98%) tick NSE

Buy Sell

Last updated on 25 Apr 2025 03:33 PM

Returns
-0.23%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

22404.88

Earning Per Share

64.6

Dividend Yield

0.45%

P/E Ratio

82.36

P/B Ratio

32.98

Debt to Equity

0.01

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value
down-img

5.34% down side

up side5.34%

ups-img

About the company

AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979. The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company. The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.

Similar Companies


Login